A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes
✍ Scribed by Wattel, E; Solary, E; Leleu, X; Dreyfus, F; Brion, A; Jouet, JP; Hoang-Ngoc, L; Maloisel, F; Guerci, A; Rochant, H
- Book ID
- 110054180
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 105 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Thirty‐three patients with recurrent or refractory Hodgkin's disease were treated with high‐dose cyclophosphamide, BCNU, and etoposide and supported with either autologous bone marrow or peripheral blood stem cells or both. Peripheral blood stem cells were comparable to bone marrow in s
## Abstract A systematic review was performed to determine whether first‐line dose‐intensive chemotherapy supported by growth factor or autologous bone marrow/stem cell transplantation improves response rate, time‐to‐disease progression, or survival compared with standard‐dose chemotherapy in patie